Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Harroud

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Brain : a Journal of Neurology|November 24, 2025
Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosisMaxime Bigotte, Adam M R Groh, Elia Afanasiev, et al.
Journal of Neurology|May 27, 2025
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Annals of Neurology|September 27, 2023
A Genetic Risk Variant for Multiple Sclerosis Severity is Associated with Brain AtrophyChristiane Gasperi, Tun Wiltgen, Julian McGinnis, et al.
BMJ Open|June 29, 2022
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosisPatrick K A Kearns, Sarah J Martin, Jessie Chang, et al.
Frontiers in Neurology|February 9, 2023
Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case reportChristopher M Bartley, Thomas T Ngo, Cathryn R Cadwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Nature Communications|July 30, 2024
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosisMajid Pahlevan Kakhki, Antonino Giordano, Chiara Starvaggi Cucuzza, et al.
Nature Medicine|October 20, 2025
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosisAhmed Abdelhak, Gabriel Cerono, Fahime Sheikhzadeh, et al.
Bioinformatics (Oxford, England)|February 10, 2023
The scalable precision medicine open knowledge engine (SPOKE): a massive knowledge graph of biomedical informationJohn H Morris, Karthik Soman, Rabia E Akbas, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Brain : a Journal of Neurology|November 24, 2025
Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosisMaxime Bigotte, Adam M R Groh, Elia Afanasiev, et al.
Journal of Neurology|May 27, 2025
Correction: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Annals of Neurology|September 27, 2023
A Genetic Risk Variant for Multiple Sclerosis Severity is Associated with Brain AtrophyChristiane Gasperi, Tun Wiltgen, Julian McGinnis, et al.
BMJ Open|June 29, 2022
FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosisPatrick K A Kearns, Sarah J Martin, Jessie Chang, et al.
Frontiers in Neurology|February 9, 2023
Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case reportChristopher M Bartley, Thomas T Ngo, Cathryn R Cadwell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Nature Communications|July 30, 2024
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosisMajid Pahlevan Kakhki, Antonino Giordano, Chiara Starvaggi Cucuzza, et al.
Nature Medicine|October 20, 2025
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosisAhmed Abdelhak, Gabriel Cerono, Fahime Sheikhzadeh, et al.
Bioinformatics (Oxford, England)|February 10, 2023
The scalable precision medicine open knowledge engine (SPOKE): a massive knowledge graph of biomedical informationJohn H Morris, Karthik Soman, Rabia E Akbas, et al.
Pageof 6